Add Company
Join Now

Sense Biodetection Revenue and Competitors

License our Company Data API

Oxford,

Location

N/A

Total Funding

Medical Equip

Industry

Estimated Revenue & Valuation

  • Sense Biodetection's estimated annual revenue is currently $8M per year.(i)
  • Sense Biodetection's estimated revenue per employee is $251,000

Employee Data

  • Sense Biodetection has 32 Employees.(i)
  • Sense Biodetection grew their employee count by -52% last year.

Sense Biodetection's People

NameTitleEmail/Phone
1
Chief Business Development Officer and FounderReveal Email/Phone
2
EVP Regulatory, Quality Assurance and Clinical AffairsReveal Email/Phone
3
Chief Financial OfficerReveal Email/Phone
4
Facilities ManagerReveal Email/Phone
5
Product Quality SpecialistReveal Email/Phone
6
Global Procurement & UK Financial Services SpecialistReveal Email/Phone
7
Tooling EngineerReveal Email/Phone
8
Scientist, Assay DevelopmentReveal Email/Phone
9
Assay Development ScientistReveal Email/Phone
10
Principal ScientistReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5M40-18%$10MN/A
#2
$24.8M9929%N/AN/A
#3
$84.1M0N/A$1.2MN/A
#4
$35.6M14230%N/AN/A
#5
$57.5M2296%N/AN/A
#6
$52.7M16825%$129.6MN/A
#7
$21.1M84-3%N/AN/A
#8
$61.2M244-13%N/AN/A
#9
$60.6M19320%$115.5MN/A
#10
$56.2M179-3%$122.9MN/A
Add Company

What Is Sense Biodetection?

Sense was founded in 2014 with a vision is to improve peoples' lives by bringing powerful tools for fast, accurate and affordable diagnostics into the hands of everyday users. It is widely accepted that empowering clinicians and consumers with point-of-care diagnostic tests will lead to improvements in patient treatment and well-being. Rather than trying to re-purpose the approaches and instruments used in the central laboratory for this purpose we are developing novel technologies that combine the power of laboratory tests with the simplicity and ease of use of low-cost consumer products.

keywords:N/A

N/A

Total Funding

32

Number of Employees

$8M

Revenue (est)

-52%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Sense Biodetection News

2022-04-13 - New CFO as Sense Biodetection scales

Global molecular diagnostics innovator Sense Biodetection – with operations in Cambridge, Oxford and Boston US – has hired a new CFO as it...

2022-03-30 - Sense Appoints Michael Jones as Chief Financial Officer

OXFORD & CAMBRIDGE, England & BOSTON, Mass.--(BUSINESS WIRE)--Global molecular diagnostics innovator, Sense Biodetection (Sense),...

2022-03-22 - Sense Biodetection sets sights on Europe after CE mark ...

The Veros COVID-19 test is a rapid molecular diagnostic for use at the point of care. Credit: Sense Biodetection Ltd. March 9, 2022. By Catherine Longworth.

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.6M327%N/A
#2
$8.4M3214%N/A
#3
$4.5M32-3%N/A
#4
N/A3239%N/A
#5
N/A3278%N/A